[HTML][HTML] Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries

T Zhao, W Wu, L Sui, Q Huang, Y Nan, J Liu, K Ai - Bioactive Materials, 2022 - Elsevier
Interventional coronary reperfusion strategies are widely adopted to treat acute myocardial
infarction, but morbidity and mortality of acute myocardial infarction are still high …

Reactive oxygen species scavenging nanomedicine for the treatment of ischemic heart disease

Z Zhang, R Dalan, Z Hu, JW Wang… - Advanced …, 2022 - Wiley Online Library
Ischemic heart disease (IHD) is the leading cause of disability and mortality worldwide.
Reactive oxygen species (ROS) have been shown to play key roles in the progression of …

[HTML][HTML] Reactive oxygen species (ROS)-responsive nanomedicine for solving ischemia-reperfusion injury

W Chen, D Li - Frontiers in Chemistry, 2020 - frontiersin.org
Ischemia-reperfusion injury (IRI) is a severe condition for most organs, which could occur in
various tissues including brain, heart, liver, and kidney, etc. As one of the major hazards …

Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries

H Amani, R Habibey, SJ Hajmiresmail… - Journal of Materials …, 2017 - pubs.rsc.org
Organ ischemia with inadequate oxygen supply followed by reperfusion (which initiates a
complex of inflammatory responses and oxidative stress) occurs in different clinical …

Recent advances in nanomedicines for imaging and therapy of myocardial ischemia-reperfusion injury

J Wang, Y Liu, Y Liu, H Huang, S Roy, Z Song… - Journal of Controlled …, 2023 - Elsevier
Myocardial ischemia-reperfusion injury (IRI) is becoming a typical cardiovascular disease
with increasing worldwide incidence. It is usually induced by the restoration of normal blood …

Rescuing cardiac cells and improving cardiac function by targeted delivery of oxygen-releasing nanoparticles after or even before acute myocardial infarction

Y Guan, H Niu, J Wen, Y Dang, M Zayed, J Guan - ACS nano, 2022 - ACS Publications
Myocardial infarction (MI) causes massive cell death due to restricted blood flow and oxygen
deficiency. Rapid and sustained oxygen delivery following MI rescues cardiac cells and …

Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances

KM Nash, S Ahmed - Nanomedicine: Nanotechnology, Biology and …, 2015 - Elsevier
Reactive oxygen species (ROS) are important in regulating normal cell physiological
functions, but when produced in excess lead to the augmented pathogenesis of various …

Reactive oxygen species (ROS)-based nanomedicine

B Yang, Y Chen, J Shi - Chemical reviews, 2019 - ACS Publications
Reactive oxygen species (ROS) play an essential role in regulating various physiological
functions of living organisms. The intrinsic biochemical properties of ROS, which underlie …

Reactive oxygen species-activated nanomaterials as theranostic agents

KS Kim, D Lee, CG Song, PM Kang - Nanomedicine, 2015 - Future Medicine
Reactive oxygen species (ROS) are generated from the endogenous oxidative metabolism
or from exogenous pro-oxidant exposure. Oxidative stress occurs when there is excessive …

[HTML][HTML] New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials

H Shi, Z Huang, T Xu, A Sun, J Ge - EBioMedicine, 2022 - thelancet.com
Myocardial infarction is lethal to patients because of insufficient blood perfusion to vital
organs. Several attempts have been made to improve its prognosis, among which …